Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6843988 | 0.84 | KDM4E (0.50) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4805749 | 0.80 | KDM4E (0.39) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL8946554 | 0.80 | LMNA (0.39) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL8071078 | 0.79 | LMNA (0.37) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL12572610 | 0.78 | KDM4E (0.61) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1408649 | 0.78 | KDM4E (0.61) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4801146 | 0.78 | LMNA (0.39) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL7655873 | 0.78 | LMNA (0.71) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4198660 | 0.78 | LMNA (0.71) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9179173 | 0.78 | LMNA (0.71) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107987887-A | A kind of oil refining apparatus increases income agent with high temperature inhibition | 浙江杭化科技股份有限公司 | 2018-05-04 | — | — | CN | claimed |
| CN-104120025-A | Hydraulic oil composition | CHANGCHUN JINBAOTE BIOLOG CHEMICAL CO LTD | 2014-10-29 | — | — | CN | claimed |
| CN-103880664-A | Method for producing high-purity and low-residue glycerol triacetate | YUNNAN PROVINCE YUXI CITY SOLVENT FACTORY CO LTD | 2014-06-25 | — | — | CN | claimed |
| CN-102168114-B | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | DU PONT | 2012-10-10 | — | — | CN | claimed |
| CN-101230176-B | Poly(vinyl alcohol) composition comprising polyol | DU PONT | 2012-09-05 | — | — | CN | claimed |
| CN-101300333-B | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | E. I. DU PONT DE NEMOURS AND CO. (US) | 2011-11-30 | — | — | CN | claimed |
| CN-101283100-B | Enzymatic production of peracids using lactobacilli having perhydrolysis activity | DU PONT | 2011-11-02 | — | — | CN | claimed |
| CN-102168114-A | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | DU PONT | 2011-08-31 | — | — | CN | claimed |
| CN-101928792-A | High-performance raw skin storage agent | LEI QIN | 2010-12-29 | — | — | CN | claimed |
| CN-101300333-A | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | DU PONT (US) | 2008-11-05 | — | — | CN | claimed |
| WO-2003002082-A1 | PRESSURIZED ANHYDROUS ANTIPERSPIRANT EMULSIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-01-09 | — | — | WO | claimed |
| US-20030007935-A1 | STABLE PRESSURIZED ANTIPERSPIRANT COMPOSITIONS CONTAINING DIMETHYLETHER PROPELLANT AND A LOW POLARITY SOLVENT | THE PROCTER & GAMBLE COMPANY | 2003-01-09 | — | — | US | claimed |
| US-6485715-B1 | Stable pressurized antiperspirant compositions containing dimethylether propellant and a low polarity solvent | THE PROCTOR & GAMBLE COMPANY | 2002-11-26 | — | — | US | claimed |
| US-6416750-B1 | MIXING ALUMINUM CHLOROHYDRATE, WATER, AND DIOL SOLVENT, SPRAY DRYING TO FORM POWDER, AND DISSOLVING INTO 1,2-DIOL SOLVENT (1,2-HEXANEDIOL); INCREASED FORMULATION FLEXIBILITY; LESS ENERGY INTENSIVE PROCESS | SOMERVILLE TECHNOLOGY GROUP, INC. | 2002-07-09 | — | — | US | claimed |
| US-6399049-B1 | LIQUID 1,2-HYDROXYALKYL AMIDE, ESTER, ETHER, SILICONE OR ALKYL COMPOUND CARRIERS; NONIRRITATING; | THE PROCTER & GAMBLE COMPANY | 2002-06-04 | — | — | US | claimed |
| EP-1206238-A2 | COMPOSITIONS CONTAINING SOLUBILIZED ANTIPERSPIRANT ACTIVE | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-22 | — | — | EP | claimed |
| EP-1206237-A1 | COMPOSITIONS CONTAINING SOLUBILIZED, ACID-ENHANCED ANTIPERSPIRANT ACTIVE | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-22 | — | — | EP | claimed |
| WO-2001013869-A2 | COMPOSITIONS CONTAINING SOLUBILIZED ANTIPERSPIRANT ACTIVE | THE PROCTER & GAMBLE COMPANY (US) | 2001-03-01 | — | — | WO | claimed |
| WO-2001013872-A1 | COMPOSITIONS CONTAINING SOLUBILIZED, ACID-ENHANCED ANTIPERSPIRANT ACTIVE | THE PROCTER & GAMBLE COMPANY (US) | 2001-03-01 | — | — | WO | claimed |
| US-6126928-A | Compositions containing solubilized, acid-enhanced antiperspirant active | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030007935-A1 | STABLE PRESSURIZED ANTIPERSPIRANT COMPOSITIONS CONTAINING DIMETHYLETHER PROPELLANT AND A LOW POLARITY SOLVENT | CDIPT, SIGMAR1, PHOSPHO1 | LMNA 2490/4885KDM4E 568/4885DUSP3 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.